valsartan has been researched along with Atrophy in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abd Elwahab, AH; Abd-Elgalil, MM; Elmongy, NF; Salama, RM; Schaalan, MF | 1 |
| Cooper, ME; Cox, AJ; Gilbert, RE; Kelly, DJ; Tolcos, M; Wilkinson-Berka, JL | 1 |
2 other study(ies) available for valsartan and Atrophy
| Article | Year |
|---|---|
LCZ696 (sacubitril/valsartan) protects against cyclophosphamide-induced testicular toxicity in rats: Role of neprilysin inhibition and lncRNA TUG1 in ameliorating apoptosis.
Topics: Aminobutyrates; Angiotensin II Type 1 Receptor Blockers; Animals; Apoptosis; Apoptosis Regulatory Proteins; Atrophy; Biphenyl Compounds; Cyclophosphamide; Drug Combinations; Endoplasmic Reticulum Stress; Humans; Male; Neprilysin; Oxidative Stress; Protease Inhibitors; Rats, Wistar; RNA, Long Noncoding; Signal Transduction; Spermatogenesis; Spermatozoa; Testis; Tetrazoles; Valsartan | 2020 |
Attenuation of tubular apoptosis by blockade of the renin-angiotensin system in diabetic Ren-2 rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Genetically Modified; Antihypertensive Agents; Apoptosis; Atrophy; Autoradiography; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Epidermal Growth Factor; Female; Fibrosis; Gene Expression; In Situ Hybridization; In Situ Nick-End Labeling; Kidney Tubules; Nephritis, Interstitial; Perindopril; Rats; Renin-Angiotensin System; RNA, Messenger; Tetrazoles; Transforming Growth Factor beta; Valine; Valsartan | 2002 |